What You Should Know:
– The American Cancer Society (ACS) and Color Health announced today a significant expansion of their existing program, creating a first-of-its-kind comprehensive cancer solution for employers and labor unions. This enhanced…
Continue Reading
What You Should Know: – Color Health, a leader in comprehensive cancer solutions, announced today a Strategic Alliance partnership with the Blue Cross Blue Shield (BCBS) National Labor Office (NLO). – Through this alliance,…
Continue Reading
What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was…
Continue Reading
Detroit-based Karmanos Cancer Institute, a network of 16 treatment locations across Michigan and Ohio that is part of McLaren Health Care, is using artificial intelligence to elevate risk assessment and is surfacing high-risk breast…
Continue Reading
By Shania Kennedy
December 05, 2023 – A deep learning model can accurately identify non-smokers at high risk for lung cancer using only routine chest X-rays, according to research presented at this year’s meeting of the…
Continue Reading
By Shania Kennedy
November 30, 2023 – Researchers from Northwestern University have developed an artificial intelligence (AI) tool that may be able to spare breast cancer patients unnecessary chemotherapy treatments by using cell patterns to predict…
Continue Reading
What You Should Know:
– The American Cancer Society (ACS) and Color Health have announced a new program to provide free lung cancer screening access to eligible individuals.
– The program will make it easy for…
Continue Reading
By Shania Kennedy
June 28, 2023 – A study published recently in Cancer Prevention Research identified seven risk factors for early onset colorectal cancer in males under the age of 50, which researchers posit may improve…
Continue Reading
By Mark Melchionna
May 12, 2023 – Published in Nature Medicine, new research led by investigators from Harvard Medical School and the University of Copenhagen describes an artificial intelligence (AI)-based tool that aims to enhance the…
Continue Reading
What You Should Know:– Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, launches publicly today with $90M in funding.– The investment comes from a syndicate of prominent tech and healthcare…
Continue Reading
